ACTINIUM AC-225 FELIVOTIDE MOPAXETAN
UNII B3YA854ZWY

Substance Identification & Data

This profile provides standardized clinical and technical data for Actinium Ac-225 Felivotide Mopaxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B3YA854ZWY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3036453-82-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B3YA854ZWY
CAS Registry Number
3036453-82-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ACTINIUM AC-225 FELIVOTIDE MOPAXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C106H150IN17O34S.Ac.3H
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
RUQYLBHOAWSEHU-XEZLDHGOSA-K
Line notation for describing the chemical structure and connectivity of atoms.
INN ID
13708
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[225Ac+3].c1c(ccc(c1)CCOc2cc(CN3CCOCCOCCN(Cc4nc(C([O-])=O)ccc4)CCOCCOCC3)nc(C([O-])=O)c2)NC(=S)NCCCC[C@@H](C(NCCOCCOCCOCCOCCOCCOCCOCCOCCC(N[C@@H](CCCCNC(CCCc5ccc(I)cc5)=O)C([O-])=O)=O)=O)NC(=O)CCOCCOCCOCCn6cc(-c7cc(NC(NCCCC[C@H](NC(N[C@@H](CCC([O-])=O)C([O-])=O)=O)C([O-])=O)=O)ccc7)nn6.[H+].[H+].[H+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Actinium Ac-225 Felivotide Mopaxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ACTINIUM (225AC) FELIVOTIDE MOPAXETAN

Common Names & Synonyms

ACTINIUM (225AC) FELIVOTIDE MOPAXETAN [INN]
ACTINIUM AC-225 FELIVOTIDE MOPAXETAN

Systematic Nomenclature

ACTINATE(3-)-225AC, (N6-(((4-(2-((2-(CARBOXY-.KAPPA.O)-6-((16-((6-(CARBOXY-.KAPPA.O)-2-PYRIDINYL-.KAPPA.N)METHYL)-1,4,10,13-TETRAOXA-7,16-DIAZACYCLOOCTADEC-7-YL-.KAPPA.N7,.KAPPA.N16,.KAPPA.O1,.KAPPA.O4,.KAPPA.O10,.KAPPA.O13)METHYL)-4-PYRIDINYL-.KAPPA.N)OXY)ETHYL)PHENYL)AMINO)THIOXOMETHYL)-N2-(3-(2-(2-(2-(4-(3-(((((5S)-5-CARBOXY-5-(((((1S)-1,3-DICARBOXYPROPYL)AMINO)CARBONYL)AMINO)PENTYL)AMINO)CARBONYL)AMINO)PHENYL)-1H-1,2,3-TRIAZOL-1-YL)ETHOXY)ETHOXY)ETHOXY)-1-OXOPROPYL)-L-LYSYL-27-AMINO-4,7,10,13,16,19,22,25-OCTAOXAHEPTACOSANOYL-N6-(4-(4-IODOPHENYL)-1-OXOBUTYL)-L-LYSINATO(6-))-, HYDROGEN (1:3)
TRIHYDROGEN ((16S)-16-((31S)-31-CARBOXYLATO-40-(4-IODOPHENYL)-29,37-DIOXO-5,8,11,14,17,20,23,26-OCTAOXA-2,30,36-TRIAZATETRACONTAN-1-OYL)-13 -(((N2 -(( L-GLUTAMATO-N-YL)CARBONYL)-L-LYSINATO-N6 -YL)CARBONYL)AMINO)-14-OXO-22-SULFANYLIDENE-5,8,11,27,304,307 ,3013,3016-OCTAOXA-15,21,23,301,3010-PENTAAZA-28(4,2),32(2)-DIPYRIDINA-2(4,1)-(1,2,3)TRIAZOLA-30(1,10)-CYCLOOCTADECANA-1(1),24(1,4)-DIBENZENADOTRIACONTAPHANE-.KAPPA.8N28.1,N30.1,N30.10 ,N32.1 ,O30.4,O30.7,O30.13,O30.16 -286,326-DI(CARBOXYLATO-.KAPPA.O))( 225AC)ACTINATE(3-)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record